#Big_pharma turns to AI to speed drug discovery, GSK signs deal | Reuters
▻http://www.reuters.com/article/us-pharmaceuticals-ai-gsk-idUSKBN19N003
When it comes to AI, big pharma is treading cautiously, in the knowledge that the technology has yet to demonstrate it can successfully bring a new molecule from computer screen to lab to clinic and finally to market.
“It’s still to be proven, but we definitely think we should do the experiment,” said John Baldoni, GSK’s head of platform technology and science.
#IA